Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01826448 |
|---|---|
| Brief Title: | A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma |
| First Submitted : | April 1, 2013 |
| First Submitted that Met QC Criteria : | April 3, 2013 |
| First Posted : | April 8, 2013 (Estimate) |
| Results First Submitted : | May 12, 2020 |
| Results First Submitted that Met QC Criteria : | May 12, 2020 |
| Results First Posted : | May 28, 2020 |
| Last Update Submitted that Met QC Criteria : | May 12, 2020 |
| Last Update Posted : | May 28, 2020 |